Bulk Inquiry
Baricitinib
- INCB 028050 - LY 3009104
- Soluble in 0.1N HCl(aq) and DMSO
- MF: C16H17N7O2S
- MW: 371.42
Description
Baricitinib is an orally bioavailable JAK1/JAK2 inhibitor with reported IC50 values of 5.9 nM for JAK1 and 5.7 nM for JAK2. It suppresses intracellular signaling downstream of multiple pro-inflammatory cytokines.
JAK1 and JAK2 transmit cytokine signals involved in immune activation, inflammation, hematopoiesis and interferon responses. Baricitinib is pharmacologically relevant for studying cytokine-driven inflammatory signaling and JAK/STAT pathway modulation.
Key Features
- Potent JAK1/JAK2 inhibitor
- Reported IC50: 5.9 nM (JAK1) and 5.7 nM (JAK2)
- Blocks cytokine-induced JAK/STAT signaling
- Relevant to inflammatory and autoimmune pathway research
Applications
- JAK/STAT signaling studies
- Cytokine response assays
- Inflammation and autoimmune disease models
- Kinase inhibitor selectivity profiling
More Information
| Parent CAS No. | 1187594-09-7 |
|---|---|
| Chemical Name | 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile |
| SMILES | N1(S(CC)(=O)=O)CC(N2C=C(C3N=CN=C4NC=CC4=3)C=N2)(CC#N)C1 |
| MFCD | N.A. |
| InChi | InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) |
| InChiKey | XUZMWHLSFXCVMG-UHFFFAOYSA-N |
| CID | 44205240 |
| Short Description | JAK1/2 inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1338 | CP 690550 |
From €60.00 |
| 1378 | AG 490 |
From €65.00 |
| 1588 | TG 101348 |
From €80.00 |
| 1598 | Ruxolitinib |
From €65.00 |
| 1681 | Momelotinib |
From €80.00 |
| 1778 | AZ 960 |
From €95.00 |
| 1843 | JAK2 inhibitor 13 |
From €110.00 |
| 1992 | AS 1517499 |
From €130.00 |
| 2072 | Tofacitinib citrate |
From €115.00 |
| 2217 | PF 956980 |
From €90.00 |
| 2219 | AT 9283 |
From €90.00 |
| 2231 | XL 019 |
From €100.00 |
| 2313 | S3I 201 |
From €90.00 |
| 2314 | Stattic |
From €50.00 |
| 2316 | WP 1066 |
From €95.00 |
| 2517 | Napabucasin |
From €105.00 |
| 2539 | Solcitinib |
From €90.00 |
| 2554 | LY 2784544 |
From €95.00 |
| 2775 | Cerdulatinib |
From €85.00 |
| 2792 | NVP-BSK805 |
From €125.00 |
| 3671 | CEP-33779 |
From €95.00 |
| 3813 | BMS-911543 |
From Inquiry |
| 3855 | AZD-4205 |
From Inquiry |
| 3950 | Peficitinib |
From €120.00 |
